APM
Avidity Partners Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.6M | Sell |
321,800
-14,200
| -4% | -$1.53M | 6.89% | 2 |
|
|
2025
Q1 | $33.9M | Sell |
336,000
-179,000
| -35% | -$18.1M | 6.46% | 1 |
|
|
2024
Q4 | $46M | Sell |
515,000
-447,000
| -46% | -$39.9M | 4.52% | 2 |
|
|
2024
Q3 | $80.6M | Sell |
962,000
-208,100
| -18% | -$17.4M | 4.11% | 1 |
|
|
2024
Q2 | $90.1M | Sell |
1,170,100
-785,900
| -40% | -$60.5M | 3.83% | 2 |
|
|
2024
Q1 | $134M | Buy |
1,956,000
+66,000
| +3% | +$4.52M | 4.32% | 2 |
|
|
2023
Q4 | $109M | Sell |
1,890,000
-175,800
| -9% | -$10.2M | 3.98% | 2 |
|
|
2023
Q3 | $109M | Buy |
2,065,800
+1,280,100
| +163% | +$67.6M | 4.39% | 1 |
|
|
2023
Q2 | $42.5M | Sell |
785,700
-64,300
| -8% | -$3.48M | 1.48% | 27 |
|
|
2023
Q1 | $42.5M | Sell |
850,000
-2,406,700
| -74% | -$120M | 1.41% | 28 |
|
|
2022
Q4 | $151M | Buy |
3,256,700
+718,100
| +28% | +$33.2M | 3.26% | 7 |
|
|
2022
Q3 | $98.3M | Buy |
2,538,600
+13,600
| +0.5% | +$527K | 2% | 15 |
|
|
2022
Q2 | $94.1M | Buy |
2,525,000
+1,328,900
| +111% | +$49.5M | 2.16% | 21 |
|
|
2022
Q1 | $53M | Buy |
+1,196,100
| New | +$53M | 1.1% | 29 |
|
|
2020
Q4 | – | Sell |
-967,100
| Closed | -$37M | – | 103 |
|
|
2020
Q3 | $37M | Buy |
+967,100
| New | +$37M | 1.71% | 17 |
|